GLP-1s in 2026: Fund Access, Protect Outcomes, Avoid the Blank Check
If you manage employer benefits, you’re staring at a 2026 puzzle: demand for GLP-1 medications keeps climbing while prices remain elevated, and oral options may expand utilization further.